These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 77568)

  • 1. Can anti HLA-A and -B antibodies inhibit the MLC test?
    Jonker M; van Rood JJ
    Tissue Antigens; 1978 Mar; 11(3):251-64. PubMed ID: 77568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of MLC responder and stimulator function with allo-antisera in rhesus monkeys.
    Widmer MB; Balner H
    Tissue Antigens; 1978 Aug; 12(2):115-31. PubMed ID: 81539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed lymphocyte culture (MLC) inhibition in humans due to anti-Ia like (DRW).
    Soulillou JP; Naud MF; Peyrat MA; Guenel J
    Pathol Biol (Paris); 1978 Dec; 26(9-10):547-51. PubMed ID: 154642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanisms by which alloantisera inhibit in the MLC test.
    Jonker M; de Rooy-Doyer L
    Tissue Antigens; 1980 Jan; 15(1):1-10. PubMed ID: 12735326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the mixed leukocyte reaction by alloantisera in man. II. Incidence and characteristics of MLC-inhibiting antisera from multiparous women.
    Jonker M; van Leeuwen A; van Rood JJ
    Tissue Antigens; 1977 May; 9(5):246-58. PubMed ID: 142317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of stimulation in murine mixed lymphocyte cultures with an alloantiserum directed against a shared Ia determinant.
    Schwartz RH; Fathman CG; Sachs DH
    J Immunol; 1976 Apr; 116(4):929-35. PubMed ID: 56405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the mixed leukocyte reaction by alloantisera in man. I. Technical aspects.
    Jonker M; van Rood JJ
    Tissue Antigens; 1977 May; 9(5):231-45. PubMed ID: 142316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of the inhibitory effect of a grand-multipara serum on MLC reactions and on responses to PHA, PWM and PPD.
    Herva E; Ilonen J
    Acta Pathol Microbiol Scand C; 1977 Dec; 85C(6):424-34. PubMed ID: 75658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antibodies cytotoxic only for B lymphocytes.
    Richiardi P; Diotallevi P; Matejc T; Carbonara AO; Curtoni ES
    Tissue Antigens; 1977 Oct; 10(4):323-9. PubMed ID: 72430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of T-cell-mediated cytolosis by alloantiserum against HLA-D-related (DR) antigens.
    Feighery CF; Stastny P
    Transplant Proc; 1979 Mar; 11(1):708-11. PubMed ID: 88098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False HLA--D assignments may be caused by cytotoxic responder lymphocytes.
    Kristensen T; Jørgensen F
    Tissue Antigens; 1978 May; 11(5):443-8. PubMed ID: 80833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The problem of preparing avid cytotoxic anti-B-lymphocyte serums].
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):142-6. PubMed ID: 77815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MLC stimulator function by antibodies directed to non-HLA antigens.
    Jonker M
    J Immunogenet; 1979 Dec; 6(6):419-27. PubMed ID: 160436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes.
    Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of alloantibodies on lymphocyte proliferation in vitro.
    Revillard JP; Betuel H; Robert M
    Cell Immunol; 1973 Sep; 8(3):339-55. PubMed ID: 4269399
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship of HLA and platelet-reactive antibodies in alloimmunized patients refractory to platelet therapy.
    Brubaker DB; Romine M
    Am J Hematol; 1987 Dec; 26(4):341-52. PubMed ID: 3687931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific blocking of MLR-stimulating determinants (HLA-D) with B-cell alloantisera: preabsorption of antibody on stimulator cells.
    Hansen JA; Lee TD; Whitsett CF; Dupont B
    Transplant Proc; 1977 Dec; 9(4):1721-6. PubMed ID: 74877
    [No Abstract]   [Full Text] [Related]  

  • 19. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
    Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
    Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.